Individuals who order Helio Genomics' test will have the option to communicate with LiverRight's healthcare providers.

Helio Genomics and LiverRight have entered into a partnership designed to improve access to early liver cancer detection in the US.

LiverRight has unveiled its groundbreaking contactless remote patient monitoring system for liver disease, simplifying health data collection during telemedicine visits.

Helio Genomics forms a strategic partnership with LiverRight to improve access to early liver cancer detection and expert care for patients across the U.S.

LiverRight, the first National Virtual Clinic for Liver Disease, appoints two prominent leaders to its Medical Advisory Board to improve liver health services for Americans.

LiverRight has introduced the Extend™ service, improving access to hepatology care for gastroenterology practices in the USA, addressing critical liver health issues.

LiverRight has launched the first national virtual clinic focused on liver disease, promising quicker appointments and comprehensive care for patients across the U.S.

Jaundice Classifier Can Detect Potential Liver Disease via the Camera Utilized in the Actual Telemedicine Visit Itself CINCINNATI, Jan. 6, 2026 /PRNewswire/ -- LiverRight, the nation's only National Virtual Clinic for diagnosing and treating Liver Disease in Adults, announces that its...

Combining breakthrough blood-based test with same-week access to board-certified hepatologists in all 50 states IRVINE, Calif., Dec. 15, 2025 /PRNewswire/ -- Helio Genomics ("Helio" or "the Company"), an AI-driven techbio company specializing in diagnostics technology for cancer...

The National Virtual Clinic for Diagnosing and Treating Adult Liver Disease Patients Adds Naim Alkhouri, MD and Rashmee Patil, MD as Advisors CINCINNATI, Sept. 24, 2025 /PRNewswire/ -- LiverRight, the nation's first and only National Virtual Clinic for diagnosing and treating Liver...